The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.
暂无分享,去创建一个
[1] J. Scolapio. Short bowel syndrome: recent clinical outcomes with growth hormone. , 2006, Gastroenterology.
[2] Takeshi Oshima,et al. Mitogenic Influence of Human R-Spondin1 on the Intestinal Epithelium , 2005, Science.
[3] J. Holst,et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients , 2005, Gut.
[4] D. Drucker,et al. Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice. , 2005, Gastroenterology.
[5] J. Holst,et al. Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[6] J. Holst,et al. GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors , 2005, Regulatory Peptides.
[7] C. Potten,et al. Teduglutide ([Gly2]GLP‐2) protects small intestinal stem cells from radiation damage , 2004, Cell proliferation.
[8] A. Theiss,et al. Growth Factors in Inflammatory Bowel Disease: The Actions and Interactions of Growth Hormone and Insulin-Like Growth Factor-I , 2004, Inflammatory bowel diseases.
[9] P. Brubaker,et al. Nutrient, neural and endocrine control of glucagon-like peptide secretion. , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[10] L. Wallace,et al. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[11] D. Ney,et al. Postreceptor resistance to exogenous growth hormone exists in the jejunal mucosa of parenterally fed rats. , 2004, The Journal of nutrition.
[12] S. Ashley,et al. Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[13] J. Holst,et al. GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets 1. , 2003, Gastroenterology.
[14] P. Brubaker,et al. Glucagon-Like Peptide-2 and Common Therapeutics in a Murine Model of Ulcerative Colitis , 2003, Journal of Pharmacology and Experimental Therapeutics.
[15] D. Ney,et al. IGF-I augments resection-induced mucosal hyperplasia by altering enterocyte kinetics. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.
[16] J. Holst,et al. Role of luminal nutrients and endogenous GLP-2 in intestinal adaptation to mid-small bowel resection. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[17] J. Slack,et al. Structural-proliferative units and organ growth: effects of insulin-like growth factor 2 on the growth of colon and skin , 2003, Development.
[18] Adrian V. Lee,et al. Local insulin-like growth factor-II mediates prolactin-induced mammary gland development. , 2003, Molecular endocrinology.
[19] P. Brubaker,et al. Role of leptin in the regulation of glucagon-like peptide-1 secretion. , 2003, Diabetes.
[20] H. Okano,et al. Candidate markers for stem and early progenitor cells, Musashi‐1 and Hes1, are expressed in crypt base columnar cells of mouse small intestine , 2003, FEBS letters.
[21] J. Fagin,et al. Mesenchymal IGF-I overexpression: paracrine effects in the intestine, distinct from endocrine actions. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[22] G. Adams. Invited Review: Autocrine/paracrine IGF-I and skeletal muscle adaptation. , 2002, Journal of applied physiology.
[23] A. Hubbs,et al. IGF‐I, IGF‐II, and IGF‐receptor‐1 transcript and IGF‐II protein expression in myostatin knockout mice tissues , 2002, Muscle & nerve.
[24] M. Gillingham,et al. Resection upregulates the IGF-I system of parenterally fed rats with jejunocolic anastomosis. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[25] R. Lea,et al. Beta-actin--an unsuitable internal control for RT-PCR. , 2001, Molecular and cellular probes.
[26] M. Bjerknes,et al. Modulation of specific intestinal epithelial progenitors by enteric neurons , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] R. Goodlad,et al. Proglucagon-Derived Peptides in Intestinal Epithelial Proliferation , 2001, Digestive Diseases and Sciences.
[28] R. Playford,et al. Gastrointestinal cell proliferation and crypt fission are separate but complementary means of increasing tissue mass following infusion of epidermal growth factor in rats , 2001, Gut.
[29] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[30] K. Rex,et al. The effects of repeated doses of keratinocyte growth factor on cell proliferation in the cellular hierarchy of the crypts of the murine small intestine. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[31] D. Greiner,et al. Thymic expression of insulin‐related genes in an animal model of autoimmune type 1 diabetes , 2001, Diabetes/metabolism research and reviews.
[32] O. Dirsch,et al. Insulin‐like growth factor I and truncated keratinocyte growth factor accelerate healing of left‐sided colonic anastomoses , 2001, The British journal of surgery.
[33] R. Tarnuzzer,et al. Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight. , 2000, The Journal of endocrinology.
[34] J. Holst,et al. GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosis. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[35] B. Yusta,et al. Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine. , 2000, Endocrinology.
[36] B. Yusta,et al. Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. , 2000, Gastroenterology.
[37] P. Yang,et al. Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse , 2000, Gut.
[38] A. Hassan,et al. Insulin-like Growth Factor II Supply Modifies Growth of Intestinal Adenoma in ApcMin/+ Mice , 2000 .
[39] M. Schwartz,et al. Glucagonlike peptide-2 analogue enhances intestinal mucosal mass after ischemia and reperfusion. , 2000, Journal of pediatric surgery.
[40] B. Yusta,et al. Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis. , 1999, American journal of physiology. Endocrinology and metabolism.
[41] C. Bondy,et al. Igf1 promotes longitudinal bone growth by insulin‐like actions augmenting chondrocyte hypertrophy , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[42] S. Grinstein,et al. Identification of Glucagon-like Peptide-2 (GLP-2)-activated Signaling Pathways in Baby Hamster Kidney Fibroblasts Expressing the Rat GLP-2 Receptor* , 1999, The Journal of Biological Chemistry.
[43] M. Adamo,et al. Investigation of Insulin-Like Growth Factor (IGF)-I and Insulin Receptor Binding and Expression in Jejunum of Parenterally Fed Rats Treated with IGF-I or Growth Hormone1. , 1999, Endocrinology.
[44] A B West,et al. Myofibroblasts. II. Intestinal subepithelial myofibroblasts. , 1999, American journal of physiology. Cell physiology.
[45] D. Podolsky,et al. Growth factors in inflammatory bowel disease. , 1999, Inflammatory bowel diseases.
[46] W. MacNaughton,et al. GLP-2 augments the adaptive response to massive intestinal resection in rat. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[47] T. Adrian,et al. An increase in mucosal insulin-like growth factor II content in postresectional rat intestine suggests autocrine or paracrine growth stimulation. , 1998, Scandinavian journal of gastroenterology.
[48] B. Evers,et al. Glucagon-like peptide 2 is a potent growth factor for small intestine and colon , 1998, Journal of Gastrointestinal Surgery.
[49] C. Cheeseman. Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo. , 1997, American journal of physiology. Regulatory, integrative and comparative physiology.
[50] D. Drucker,et al. Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2. , 1997, American journal of physiology. Gastrointestinal and liver physiology.
[51] D. Drucker,et al. Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV , 1997, Nature Biotechnology.
[52] D. Drucker,et al. Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. , 1997, The American journal of physiology.
[53] D. Drucker,et al. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. , 1997, The American journal of physiology.
[54] D. Ney,et al. GH elevates serum IGF-I levels but does not alter mucosal atrophy in parenterally fed rats. , 1997, The American journal of physiology.
[55] D. Drucker,et al. Biological determinants of intestinotrophic properties of GLP-2 in vivo. , 1997, The American journal of physiology.
[56] A. D'ercole,et al. Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I. , 1997, Gastroenterology.
[57] D. Drucker,et al. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[58] C. Potten,et al. Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in vivo administration of growth factors. , 1995, Gut.
[59] M. Ulshen,et al. Regulation and localization of the insulin-like growth factor system in small bowel during altered nutrient status. , 1995, The American journal of physiology.
[60] C. Graham,et al. Disproportionate growth in mice with Igf-2 transgenes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[61] J. Ryan,et al. Determination of the histological distribution of insulin like growth factor 1 receptors in the rat gut. , 1993, Gut.
[62] L. Powell-Braxton,et al. IGF-I is required for normal embryonic growth in mice. , 1993, Genes & development.
[63] L. Powell-Braxton,et al. Inactivation of the IGF‐I Gene in Mice Results in Perinatal Lethality , 1993, Annals of the New York Academy of Sciences.
[64] R. Dowling,et al. Enhanced growth of small bowel in transgenic mice overexpressing bovine growth hormone. , 1993, Gastroenterology.
[65] F. Ballard,et al. Insulin-like growth factor-I and its N-terminal modified analogues induce marked gut growth in dexamethasone-treated rats. , 1992, The Journal of endocrinology.
[66] Jon S Thompson,et al. Short bowel syndrome. , 1996, Clinics in perinatology.
[67] N. Wright,et al. Morphometry and cell proliferation in endoscopic biopsies: evaluation of a technique. , 1991, Gastroenterology.
[68] A. Efstratiadis,et al. Parental imprinting of the mouse insulin-like growth factor II gene , 1991, Cell.
[69] A. Efstratiadis,et al. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting , 1990, Nature.
[70] P. Brubaker. Control of glucagon-like immunoreactive peptide secretion from fetal rat intestinal cultures. , 1988, Endocrinology.
[71] E. Adashi,et al. Insulin-like growth factor-I as an amplifier of follicle-stimulating hormone action: studies on mechanism(s) and site(s) of action in cultured rat granulosa cells. , 1988, Endocrinology.
[72] H Cheng,et al. The crypt cycle. Crypt and villus production in the adult intestinal epithelium. , 1987, Biophysical journal.
[73] V. Han,et al. Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. , 1987, Science.
[74] B. Moats-Staats,et al. Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. , 1986, The Journal of biological chemistry.
[75] Hideyuki Okano,et al. Identification of a putative intestinal stem cell and early lineage marker; musashi-1. , 2003, Differentiation; research in biological diversity.
[76] Christopher S Potten,et al. The intestinal epithelial stem cell. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.
[77] D. Le Roith,et al. Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles. , 2001, Annual review of physiology.
[78] B. Yusta,et al. Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor. , 2001, Cancer research.
[79] D. Drucker,et al. Enzymatic- and renal-dependent catabolism of the intestinotropic hormone glucagon-like peptide-2 in rats. , 2000, American journal of physiology. Endocrinology and metabolism.
[80] B. Yusta,et al. Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[81] P. Lund. IGFs and the Digestive Tract , 1999 .
[82] J. Holst,et al. Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs. , 1998, Scandinavian journal of gastroenterology.
[83] J. Wallace,et al. Continuous 14 day infusion of IGF-II increases the growth of normal female rats, but exhibits a lower potency than IGF-I. , 1995, The Journal of endocrinology.
[84] D. Drucker,et al. Printed in U.S.A. Copyright © 1997 by The Endocrine Society Circulating and Tissue Forms of the Intestinal Growth Factor, Glucagon-Like Peptide-2* , 2022 .